Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Geolix.ai Joins Airwallex to Show Why Ranking #1 on Google No Longer Puts a Brand in the AI Answer

September 13, 2026

Trump drops tariff on Irish whiskey while booze ban looms for Canada

September 13, 2026

Planner Bee Expands Insurance Comparison Platform Covering 29 Singapore Insurers

September 13, 2026

Carney’s investment summit to be met with protests

September 13, 2026

Carney, Macron to meet as talks of stronger Canada-EU relationship ramp up

September 13, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Curative Therapeutics Market Size, Share, Trends, Opportunity, and Forecast to 2030: Value-Based Pricing Gains Traction, Enhancing Global Market Access
Press Release

Curative Therapeutics Market Size, Share, Trends, Opportunity, and Forecast to 2030: Value-Based Pricing Gains Traction, Enhancing Global Market Access

By News RoomJanuary 6, 20263 Mins Read
Curative Therapeutics Market Size, Share, Trends, Opportunity, and Forecast to 2030: Value-Based Pricing Gains Traction, Enhancing Global Market Access
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) — The “Curative Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” has been added to ResearchAndMarkets.com’s offering.

The Global Curative Therapeutics Market will grow from USD 485.21 Million in 2024 to USD 762.72 Million by 2030 at a 7.83% CAGR. The market’s expansion is primarily driven by the substantial global burden of chronic and rare diseases, coupled with continuous advancements in biotechnological platforms such as gene editing and cell therapies, and increasing investments in research and development accelerating the pipeline of novel candidates.

Key Market Drivers

Breakthroughs in cell and gene therapy represent a paramount driver for the global curative therapeutics market, fundamentally reshaping treatment paradigms for previously intractable diseases. These advanced modalities offer potential for one-time cures by correcting underlying genetic defects or harnessing the body’s immune system to combat illness.

The accelerating pace of innovation, evidenced by novel therapeutic approvals, signifies platform maturation. According to RegMedNet, in May 2025, “FDA-Approved Cell and Gene Therapies”, the US Food and Drug Administration approved nine cell and gene therapy products in 2024, targeting conditions such as cancer, hemophilia B, and aromatic L-amino acid decarboxylase deficiency. This demonstrates expanding regulatory confidence and the broader scope of conditions amenable to these revolutionary approaches.

Key Market Challenges

A significant challenge impeding the expansion of the Global Curative Therapeutics Market is the high upfront cost associated with developing and delivering these complex therapies. This factor directly creates affordability concerns for healthcare systems and patients, consequently limiting widespread access and consistent reimbursement for treatments, even those demonstrating high efficacy. Such substantial costs strain national healthcare budgets and individual patient finances, thereby hindering the broader adoption necessary for robust market growth.

Key Market Trends

Increased Payer Acceptance of Value-Based Pricing for Curative Therapies is significantly influencing the global curative therapeutics market by providing new frameworks for drug reimbursement. This trend addresses the substantial upfront costs of these advanced treatments by linking payment to predefined clinical outcomes or long-term efficacy, thereby reducing financial risk for healthcare systems and fostering greater market access. This approach encourages a shift from volume-based to value-based healthcare, where the economic burden is shared, and therapies are evaluated on their demonstrated patient benefit.

Key Market Players Profiled:

  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Bluebird bio, Inc.
  • Novartis AG
  • Spark Therapeutics, Inc.
  • Gilead Sciences, Inc.
  • Sarepta Therapeutics, Inc.
  • Vertex Pharmaceuticals Incorporated
  • Alnylam Pharmaceuticals, Inc.

Report Scope

In this report, the Global Curative Therapeutics Market has been segmented into the following categories:

By Type:

  • Biology Modifying Drugs
  • Gene Therapies
  • Cell Therapies

By Indication:

  • Cancer
  • Musculoskeletal Disorders
  • Neurodegenerative Diseases
  • Rare Diseases
  • Hepatitis C
  • Others

By End User:

  • Pharmaceutical Companies
  • Academic & Research Institutions
  • Others

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Key Attributes

Report Attribute Details
No. of Pages 185
Forecast Period 2024-2030
Estimated Market Value (USD) in 2024 $485.21 Million
Forecasted Market Value (USD) by 2030 $762.72 Million
Compound Annual Growth Rate 7.8%
Regions Covered Global

For more information about this report visit https://www.researchandmarkets.com/r/xouo5e

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Curative Therapeutics Market

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Geolix.ai Joins Airwallex to Show Why Ranking #1 on Google No Longer Puts a Brand in the AI Answer

Planner Bee Expands Insurance Comparison Platform Covering 29 Singapore Insurers

Apeing Presale Surpasses $80,000 as Stage 3 Progresses Toward Scheduled Stage 4 Launch

Apeing Opens Stage 3 of $APEING Presale at $0.0004 as Project Advances Its 33-Stage Token Sale

Apeing Presale Surpasses $80,000 in Contributions as Stage 4 Launch Approaches

Crypto Price Today Highlights Solana Momentum as Apeing’s New Crypto Presale Stage 3 Almost Sold Out

JD.com’s 7Fresh Kitchen: “Chef Transformer” is coming!

REGN 2-DAY DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

Building Global Trust in the AI Search Era: DigiMentumPR Explores the Future of PR for Technology Brands

Editors Picks

Trump drops tariff on Irish whiskey while booze ban looms for Canada

September 13, 2026

Planner Bee Expands Insurance Comparison Platform Covering 29 Singapore Insurers

September 13, 2026

Carney’s investment summit to be met with protests

September 13, 2026

Carney, Macron to meet as talks of stronger Canada-EU relationship ramp up

September 13, 2026

Latest News

Apple is reportedly working on iPhone game controllers

September 13, 2026

Saskatoon rally for the unhoused calls for action on forced displacement

September 13, 2026

Celine Dion kicks off 1st show in 6 years at Paris residency: ‘I missed this’

September 13, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version